Information Letter on Pixuvri® 29 mg powder for concentrate for solution for infusion (pixantrone): Risk of dosing errors
2013.11.19
Active substance: pixantrone
The company CTI Life Sciences Limited in Great Britain points out that there is a risk of dosing errors when taking Pixuvri® (active substance: pixantrone), since the dose recommended in the EU is different as compared to that stated in some studies and publications.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN